Lead sponsor
FUJIFILM Toyama Chemical Co., Ltd.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
1,076
Total enrollment
121
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
3
Trials by status
Completed
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)mild-to-moderate ADPh 2Completed482
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Diseasemild-to-moderate ADPh 2Completed373
Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild ADMCI due to ADPh 2Completed221